Page last updated: 2024-09-05

symmetric dimethylarginine and Arteriosclerosis Obliterans

symmetric dimethylarginine has been researched along with Arteriosclerosis Obliterans in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guntani, A; Honma, K; Itoh, H; Iwasa, K; Kyuragi, R; Maehara, Y; Matsumoto, T; Ohmine, T; Onohara, T	1

Trials

1 trial(s) available for symmetric dimethylarginine and Arteriosclerosis Obliterans

Article	Year
The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans. International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:2 Suppl Topics: Administration, Oral; Aged; Ankle Brachial Index; Arginine; Arteriosclerosis Obliterans; Biomarkers; Endothelin-1; Epoprostenol; Exercise Test; Exercise Tolerance; Humans; Intermittent Claudication; Platelet Aggregation Inhibitors; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents; Walking	2010

Article

Year

The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.

International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:2 Suppl

Topics: Administration, Oral; Aged; Ankle Brachial Index; Arginine; Arteriosclerosis Obliterans; Biomarkers; Endothelin-1; Epoprostenol; Exercise Test; Exercise Tolerance; Humans; Intermittent Claudication; Platelet Aggregation Inhibitors; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation; Vasodilator Agents; Walking

2010